skip to main content
Back to Top

The COVID-19 Resource Canada Site

Funding opportunities

The Science | Business Repository of COVID-19 Related

Funding opportunities 


New Horizons for Seniors Program: Community-based projects

Application deadline: October 20, 2020 3 p.m. EST
Funding available: $25,000 

Priorities include: Supporting healthy ageing, preventing elder abuse and fraud, combatting ageism, celebrating diversity and promoting inclusion, improving seniors’ access to government services and benefits, adapting community-based organizations to a more virtual environment. Program objectives: promoting volunteerism among seniors and other generations, engaging seniors in the community through the mentoring of others, expanding awareness of elder abuse, including financial abuse, supporting the social participation and inclusion of seniors, and providing capital assistance for new and existing community projects and programs for seniors.

More information


Government of Canada New Frontiers in Research Fund (NFRF) Exploration 2020 Grant

Notification of Intent (NOI) to Apply: August 18, 2020 8 p.m. EST
Application deadline: October 20, 2020 8 p.m. EST
Funding available: Up to $125,000 up to 2 years (total available funding $25M over 2 years)

The Exploration grant goal is to inspire high-risk, high-reward and interdisciplinary research. Exploration grants support research that pushes boundaries into exciting new areas. Researchers are encouraged to think “outside of the box,” undertake research that would defy current paradigms, and bring disciplines together in unexpected ways and from bold, innovative perspectives. Exploration stream grants support projects that bring disciplines together beyond traditional disciplinary or common interdisciplinary approaches; propose to explore something new, which might fail; and have the potential for significant impact. Exploration grants support research with a range of impacts, some of which might be social, cultural, economic, health-related, or technological. This list is not exhaustive; other types of impacts are also recognized. Diversity of perspectives is important, and the fund encourages research proposals led from any discipline, from those in the social sciences and humanities, to health, the natural sciences and engineering. 

More information


Michael J. Fox Foundation for Parkinson’s Research | Accelerating publication of Parkinson’s disease replication data

Pre-submission deadline: October 22, 2020 5 p.m. EST
Full manuscript invitations: November 20, 2020
Full manuscript submissions due (by invite only): January 8, 2021, 5 p.m. EST
Funding available: Publication /access fees

To address the bias toward the publication of novel positive results, The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and the Journal of Parkinson’s Disease (JPD) invite researchers to “open their notebooks” and submit unpublished results from experiments that attempted to replicate previously published findings from other laboratories. By encouraging the rapid peer-review and publication of these datasets, we hope to increase the available information around previously published, high-impact findings. Applicants will submit a two-page “Pre-submission” to MJFF for initial review. Successful applicants will be invited to submit a manuscript to JPD for peer review. Manuscripts passing peer review will be published in JPD. Authors of manuscripts selected for publication will pay no publication or Open Access fees.

More information


Michael J. Fox Foundation for Parkinson’s Research | Analysis of patient-reported outcomes (PROs) from Fox Insight

Pre-proposals deadline: October 22, 2020 5 p.m. EST
Full proposal invitations: December 21, 2020
Full proposal due (by invite only): March 18, 2021, 5 p.m. EST
Funding available: Up to $100,000 for one-year grants

PROs collected in Fox Insight capture information on the lives experience of Parkinson’s that can transform therapeutic development, clinical care, and public policy for people with the disease. Data from tens of thousands of people with and without Parkinson’s participating in the study provides the necessary power to generate new understanding of a heterogeneous disease. Investigators unfamiliar with Parkinson’s who present compelling proposals for methods may be paired with a Parkinson’s expert for contextualizing analysis to clinical practice. The dataset and additional resources are available in the Fox Insight Data Exploration Network (Fox DEN).

More information


Michael J. Fox Foundation for Parkinson’s Research | Development and Validation of Improved Outcome Measures Analysis 

Pre-proposals deadline: October 22, 2020 5 p.m. EST
Full proposal invitations: December 21, 2020
Full proposal due (by invite only): March 18, 2021, 5 p.m. EST
Funding available: Up to $750,000 for two years

The Michael J. Fox Foundation (MJFF) seeks applications to develop objective biomarkers that can support therapeutic development in Parkinson’s. These may include biomarkers that improve definitive diagnosis, objectively track disease progression, enrich for subject populations, or more precisely detect a treatment response or target engagement. The availability of these types of biomarkers would transform clinical trial design and assist in the interpretation of trial results.

More information


Michael J. Fox Foundation for Parkinson’s Research | PIPETTE: 4R tau and alpha-synuclein PET tracer development

Pre-proposals deadline: October 22, 2020 5 p.m. EST
Full proposal invitations: December 21, 2020
Full proposal due (by invite only): March 18, 2021, 5 p.m. EST
Funding available: Total funding available is $1 million

The PIPETTE Consortium (Philanthropic Investments in PET TracErs) is a funding partnership formed in 2017 by The Michael J. Fox Foundation and Rainwater Charitable Foundation (conveners of the Tau Consortium). The partnership’s goal is to accelerate the development of novel 4R tau and alpha-synuclein PET tracers for primary non-Alzheimer’s tauopathies, Parkinson’s disease, Lewy body dementia, frontotemporal dementia, and other neurodegenerative diseases. As a collaborative effort of leading non-profit organizations, the PIPETTE Consortium seeks to pool ideas, expertise, and resources to enable improved diagnosis and treatment of multiple disorders.

More information


Michael J. Fox Foundation for Parkinson’s Research | Target advancement program

Pre-proposals deadline: October 22, 2020 5 p.m. EST
Full proposal invitations: December 21, 2020
Full proposal due (by invite only): March 18, 2021, 5 p.m. EST
Funding available: Up to $150,000 for 18 to 24 months

The Michael J. Fox Foundation believes that promoting target and pathway validation studies within academic and industry laboratories can bridge the critical gap between basic biology and therapeutic development. Validation efforts should focus on early-stage targets that have previously been implicated in Parkinson’s but have not yet been rigorously tested for their ability to impact disease-relevant outcomes in Parkinson's model systems. Submitted projects should investigate whether genetic or pharmacological modulation of the target can affect Parkinson's-relevant biological pathways or phenotypes in model systems that may be predictive of therapeutic efficacy.

More information


Michael J. Fox Foundation for Parkinson’s Research | Therapeutic pipeline program

Pre-proposals deadline: October 22, 2020 5 p.m. EST
Full proposal invitations: December 21, 2020
Full proposal due (by invite only): March 18, 2021, 5 p.m. EST
Funding available: Up to $500,000 for one- to two-year pre-clinical grants; Up to $2 million for two- to three-year clinicals grants

The Michael J. Fox Foundation seeks applications with potential for fundamentally altering disease course and/or significantly improving treatment of symptoms above and beyond current standards of care. The Therapeutic Pipeline Program is open to industry and academic investigators proposing novel approaches or repositioning approved or clinically safe therapies from other disease indications.

More information


Alzheimer’s Drug Discovery Foundation

Letter of intent deadline: October 9, 2020
Proposal deadline: November 6, 2020

The Alzheimer’s Drug Discovery Foundation provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias. We have dedicated our funding to several key areas: Translational research to develop new drugs and build preclinical evidence, IND-enabling studies and early-stage clinical trials for novel and repurposed drugs, Development and validation of plasma, CSF, neuroimaging and digital biomarkers, Epidemiological studies and comparative effectiveness research. 

More information


Pooler Charitable Fund 2020 Research Grant Opportunities

Internal HRS Deadline: November 17, 2020
Application deadline: December 1, 2020
Funding available: $55,000 for Alzheimer's Disease; $45,000 for Macular Degeneration and Autism; and $35,000 for Bipolar Disorder.

More information


The W. Garfield Weston Foundation Brain Health 2021: Lifestyle approaches and microbiome contributions

Letter of intent deadline: November 25, 2020
Proposal deadline: April 15, 2021
Funding available: Up to $1.5 million per project up to three years

The program seeks to increase the number of Canadians maintaining better brain health throughout their lives. This program aims to advance the treatment (e.g., symptomatic relief, disease modification) and/or prevention of neurodegenerative diseases of aging by accelerating the development and implementation of lifestyle approaches and/or identifying the contribution of the microbiome.

More information


Ontario Trillium Foundation Resilient Communities Fund

Application deadline: December 2, 2020 5 p.m. EST
Funding available: From $5,000 to $150,000 for up to one year

The Ontario Trillium Foundation is investing in projects of eligible non-profit organizations to aid their medium to longer-term recovery efforts, help with their stabilization and build their capacity and resiliency in the aftermath of COVID-19. This fund is providing a flexible range of activities over two deadlines to address the diverse needs of organizations and to support them where they are at in their recovery and rebuilding.

More information


NIA Novel Mechanism Research on Neuropsychiatric Symptoms in Alzheimer's Dementia (R01 Clinical Trial Optional)

Application deadline: February 5, 2021
Funding available: Application budgets are not limited but need to reflect proposed project needs

The goal of this call is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms in persons with Alzheimer's disease or Alzheimer's disease-related dementias. This call uses the R01 mechanism, while the companion call PAR-20-159 uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism.

More information


Dementia Consortium

Application deadlines: Expression of Interest is reviewed every two months, while full applications (invitation only) are reviewed every three months. Check the website for the next deadline
Funding available: £100,000 to £250,000 (£500,000 for exceptional cases)

The consortium brings together publicly backed funders of medical research, experts in scientific assessment, and the scale and strength of industry to support the development of promising research. The consortium seeks promising research from academia and considers appropriate funding and development routes. Once complete, successful projects may be moved towards the clinic by industry, and all parties share in the success.

More information


The W. Garfield Weston Foundation: Early Phase Clinical Trials

Letter of intent deadline: Rolling
Funding available: Up to $1.5 million per project up to four years

Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. Diseases such as Alzheimer’s and Parkinson’s are placing a large and increasing burden on society. If ignored, the social and economic costs of managing these diseases will rise significantly within a generation. Meeting these challenges requires pioneering approaches to accelerating treatments. The Early Phase Clinical Trials: Canada program was created to provide funding support for clinical trials and clinical trial sub-studies with excellent preliminary data. 

More information


NSERC Alliance

Application deadline: applications are currently being accepted for Option 1 and 2
Funding available: $20,000 to $1,000,000 per year for one to five years

NSERC Alliance grants encourage university researchers to collaborate with partner organizations, which can be from the private, public or not-for-profit sectors. Funding may support research and development projects that seek to respond to a research challenge in the natural sciences or engineering, while working with external partners who are able to accelerate scale-up, application, impact, or commercialization. NSERC is now accepting Option 1 applications requiring at least 50 per cent matching cash contributions from partner organizations, and for Option 2, involving non-profit partners and requesting 90 to 100 per cent funding support from NSERC.


Physician’s Services Incorporated (PSI) Foundation Health Research Grant 

More information

New Investigator Research Grant 

More information

Application deadline: Applications may be submitted at any time
Funding available: Up to $250,000 for a maximum of three years (maximum $100,000 in any one year)

PSI’s granting interests are in two areas: Education of practising physicians, and health research with an emphasis on research relevant to patient care. The Foundation’s support of health research is offered in the following areas: clinical research, medical education research at the post MD level, health systems research, and health care research by community physicians.


Birks Family Foundation Grant

Application deadline: Rolling (apply six months prior to when funds would be required)
Funding available: Application dependent

The Birks Family Foundation funds organizations either primarily focused on Quebec, or those whose work is broadly national in nature; Public sector organizations, including universities, hospitals, libraries and museums; Projects that demonstrate unique innovation in their field and/or pioneer state-of-the-art technology; Long range projects designed to become self-sustaining; and, organizations that actively engage directly with their target group through programs and/or services.

More information

Email MIRA at: MIRAinfo@mcmaster.ca       Follow us on Twitter : @MIRAMcMaster
McMaster Footer Logo
Institute For Research On Aging Footer Logo

© 201​6 McMaster University  |  MIP Suite 109A, 1280 Main St. W., Hamilton, ON L8S 4K1  |  Contact Us  | Email UsTerms of Use & Privacy Policy